Merrimack Pharmaceuticals Secures $77,000,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8370e71d-2d5b-44c8-b5bc-d90cdcac10ac&Preview=1 -
Date
4/14/2011 -
Company Name
Merrimack Pharmaceuticals -
Mailing Address
One Kendall Square Cambridge, MA 02139 -
Company Description
Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer. -
Website
http://www.merrimackpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$77,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds from the financing will be used to advance Merrimack’s proprietary pipeline of novel targetedcancer therapeutics. -
M&A Terms
-
Venture Investor
Undisclosed
